INSM
Price
$145.18
Change
+$9.08 (+6.67%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
28.77B
51 days until earnings call
THAR
Price
$5.16
Change
-$0.79 (-13.28%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
31.39M
Interact to see
Advertisement

INSM vs THAR

Header iconINSM vs THAR Comparison
Open Charts INSM vs THARBanner chart's image
Insmed
Price$145.18
Change+$9.08 (+6.67%)
Volume$68.05K
Capitalization28.77B
Tharimmune
Price$5.16
Change-$0.79 (-13.28%)
Volume$21.08K
Capitalization31.39M
INSM vs THAR Comparison Chart in %
Loading...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSM vs. THAR commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a Buy and THAR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (INSM: $136.10 vs. THAR: $5.95)
Brand notoriety: INSM and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 65% vs. THAR: 42%
Market capitalization -- INSM: $28.77B vs. THAR: $31.39M
INSM [@Biotechnology] is valued at $28.77B. THAR’s [@Biotechnology] market capitalization is $31.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileTHAR’s FA Score has 0 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • THAR’s FA Score: 0 green, 5 red.
According to our system of comparison, INSM is a better buy in the long-term than THAR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 4 TA indicator(s) are bullish while THAR’s TA Score has 5 bullish TA indicator(s).

  • INSM’s TA Score: 4 bullish, 4 bearish.
  • THAR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both INSM and THAR are a good buy in the short-term.

Price Growth

INSM (@Biotechnology) experienced а +3.20% price change this week, while THAR (@Biotechnology) price change was +26.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

INSM is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($28.8B) has a higher market cap than THAR($31.4M). THAR YTD gains are higher at: 193.103 vs. INSM (97.132). THAR has higher annual earnings (EBITDA): -11.99M vs. INSM (-938.1M). INSM has more cash in the bank: 1.86B vs. THAR (2.24M). THAR has less debt than INSM: THAR (250K) vs INSM (576M). INSM has higher revenues than THAR: INSM (398M) vs THAR (0).
INSMTHARINSM / THAR
Capitalization28.8B31.4M91,720%
EBITDA-938.1M-11.99M7,821%
Gain YTD97.132193.10350%
P/E RatioN/A0.02-
Revenue398M0-
Total Cash1.86B2.24M82,828%
Total Debt576M250K230,400%
FUNDAMENTALS RATINGS
INSM: Fundamental Ratings
INSM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
5
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INSMTHAR
RSI
ODDS (%)
Bearish Trend 5 days ago
76%
Bearish Trend 5 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 5 days ago
89%
MACD
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 5 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
70%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
75%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JHS11.580.02
+0.17%
John Hancock Income Securities Trust Capital Stock
PMAP25.68N/A
N/A
PGIM S&P 500 Max Buffer ETF - April
DFEM30.86-0.17
-0.55%
Dimensional Emerging Markets Cr Eq 2 ETF
GK24.95-0.40
-1.57%
AdvisorShares Gerber Kawasaki ETF
FNGO113.42-4.17
-3.54%
MicroSectors™ FANG+™ 2X Leveraged ETN

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with CDTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
-1.65%
CDTX - THAR
82%
Closely correlated
+0.25%
RNAC - THAR
81%
Closely correlated
-2.24%
NCNA - THAR
81%
Closely correlated
-0.31%
TAOX - THAR
79%
Closely correlated
-11.08%
JAGX - THAR
79%
Closely correlated
+1.87%
More